Clinical trial
Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney Disease
NCT06639529 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney Disease
- Lead sponsor
- The First Hospital of Jilin University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 10, 2024
- Completion date
- July 30, 2024
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic kidney disease (dkd)